The basics of launching a pharmaceutical drug-
Based on studies done on the practices of 13 top pharmaceutical companies in the world.
For more, write to info@markivmedical.com
Pre-Launch Planning: Priming Your Pharma Brand For Profit And Success (mini)Eularis
In today’s environment, Pharmaceutical companies find themselves in a bind. Until recently, if drugs made over $500 Million in annual revenue within 3 to 5 years of launch, they were considered hugely successful. They were a support to an extensive company portfolio and a component of greater company profit.
However, things have changed. The standards for a successful drug have become much higher and much more dangerous. With so many revenue-producing drugs going off patent, companies are facing large holes in their balance sheets and sales that are increasingly slow.
Plus, with the stakes high and available funds low, pipelines are drying up. Add to this the closer scrutiny of safety issues, the rise of Generics, slower physician acceptance and adoption of new therapies, and the Pharma Industry is in trouble.
More and more, companies are expecting marketers to be instrumental at the key moment of launch, and marketers are under extreme pressure. To deliver on the high hopes of Pharmaceutical brand launch, companies must engage in comprehensive pre-launch planning.
In this report we analyze why launch is increasingly important, the issues involved in pre-launch planning, including key organizational strategies, marketing tactics, regulatory considerations, global issues, and methods for ensuring the most effective plans.
The basics of launching a pharmaceutical drug-
Based on studies done on the practices of 13 top pharmaceutical companies in the world.
For more, write to info@markivmedical.com
Pre-Launch Planning: Priming Your Pharma Brand For Profit And Success (mini)Eularis
In today’s environment, Pharmaceutical companies find themselves in a bind. Until recently, if drugs made over $500 Million in annual revenue within 3 to 5 years of launch, they were considered hugely successful. They were a support to an extensive company portfolio and a component of greater company profit.
However, things have changed. The standards for a successful drug have become much higher and much more dangerous. With so many revenue-producing drugs going off patent, companies are facing large holes in their balance sheets and sales that are increasingly slow.
Plus, with the stakes high and available funds low, pipelines are drying up. Add to this the closer scrutiny of safety issues, the rise of Generics, slower physician acceptance and adoption of new therapies, and the Pharma Industry is in trouble.
More and more, companies are expecting marketers to be instrumental at the key moment of launch, and marketers are under extreme pressure. To deliver on the high hopes of Pharmaceutical brand launch, companies must engage in comprehensive pre-launch planning.
In this report we analyze why launch is increasingly important, the issues involved in pre-launch planning, including key organizational strategies, marketing tactics, regulatory considerations, global issues, and methods for ensuring the most effective plans.
Budget Allocation for a Successful Bio-Pharma Product LaunchBest Practices
Bio-Pharma companies can no longer afford to rely solely on past experiences when budgeting for a new product launch in today's fast-changing, highly competitive market. This comprehensive benchmark study by Best Practices, LLC investigates current costs as well as budget and staffing allocations required for a successful drug launch.
This study can help bio-pharma leaders to develop competitive launch and pre-launch activity budgets to ensure successful U.S. market entry for new products.
Download Full Report: http://bit.ly/2aMYron
detailed evaluation of the marketing mix of sun pharmaceutical company, the advantages & disadvantages of the 7 P's with reference to the sun pharma and a strategic evaluation of their marketing strategy compared to Dr. Reddy
Global Generic Pharmaceutical Market - Qualitative and Quantitative AnalysisAiswariya Chidambaram
This report was presented at the Pharma Tech 2013 Conference - India A Game Changer in the Pharma Industry at Ahmedabad, India in December 2013. The presentation highlights the overview of the global generic pharmaceuticals market, with particular focus on the key market trends and challenges by therapeutic areas and geographies including the U.S, EU and India. List of key blockbuster drugs scheduled to lose patent protection between 2010 and 2020 have been included. Additionally impact of regulation on generic drugs by region and strategic recommendations for the success of market participants are also covered in this report.
Pharmaceutical Marketing plan, Brand Plan, Launch Plan
1. How To Make Marketing Plan for Pharmaceutical Product ,
2. , What is Marketing Plan? All of the strategies, including the four Ps and segmentation, targeting, and positioning, come together in the marketing plan. , 2
3. , Marketing Plan The marketing plan may be Product specific, market specific, or company-wide plan that describes activities involved in achieving specific marketing objectives within a set timeframe. A market plan begins with the identification (through market research) of specific customer needs and how the firm intends to fulfill them while generating an acceptable level of return. It generally includes analysis of the current market situation (opportunities and trends) and detailed action programs, budgets, sales forecasts, strategies, and projected financial statements. , 3
4. , Pharmaceutical companies Pharmaceutical manufacturing companies typically employ product managers to be responsible for the details of a particular medication. The product manager and his or her team usually assemble marketing plans for the specific products they oversee. Although reprinting a real company’s pharmaceutical marketing plan would be the best way to demonstrate marketing plans, the information contained in such a document is highly confidential. , 4
5. . 5
6. , Content of Marketing Plan Executive Summary Situational Analysis Disease Overview Market Analysis Competitive analysis SWOT Analysis Strategic planning Segmentation Targeting Position Marketing Mix Objectives, Strategies, and Tactics Financial Outlook Control, Evaluation , 6
7. , Executive Summary , 7
8. , Executive Summary Overview of the marketing plan Highlights key areas, decisions, and expected outcomes. , 8
9. , ExecutiveSummary 9 • Total Pharma Market is Rs. 268.2 billion with a growth rate of 11.60%. • Anti Ulcerant (A2B) market is of Rs. 13.29 billion with a value share of 5%, growing by 14.72%. • Anti Ulcerant market is further divided in two therapeutic classes; – Histamine 2 Receptors Antagonists (A2B1) worth Rs. 1.76 bio growing by 3.87. – Proton Pump Inhibitors (A2B2) worth Rs. 11.08 bio growing by 16.62. • The largest pie of this market has been captured by Getz Pharma, together with Risek (Rs. 2.42 bio) & Nexum (Rs.1.05 bio) Getz is enjoying a value share of more than 3 Billion Rupees of PPI market. • Besides Risek & Nexum, Ruling, Esso has become a brand of Rs.737 & 728 m. • Despite fierce competition and much bigger stake holders in market, Brand X managed to make its footing by marking a value share of Rs. 30 million in the first year of Its launch. ,
10. , Situation Analysis ,
11. , Situation Analysis This section describes where your company stands at that moment in time. It includes background on past sales, major competitors, and explanations of recent sales and profit results. ,
12. , Disease Overview •Prevalence rate in country; number of patients
This PPT contains complete analysis of Pharmaceutical Industry including worldwide and nationwide picture, leading organizations, SWOT analysis, Government policies and regulations, challenges and solutions.
Our Product Marketing Plan Playbook is a planning methodology that highlights our premium tool-kit of tools & templates to develop a comprehensive product marketing plan.
Generic Pharma 2.0 Masters of Business Development & MarketingGeneric Pharma 2.0
Introduction to Generic Pharma 2.0
- Business Development Toolkit
- Portfolio Consulting
- Digital Marketing
- Lead Generation & Conversion
- Design & Creative
Description of the Brand Booster Program which includes three innovative marketing approaches: the Brand Preference Mix to increase market share - the Behavioral Prescriber Segmentation to increase the efficiency of field forces and the Individual Prescriber Plan to fine tune the marketing mix
Budget Allocation for a Successful Bio-Pharma Product LaunchBest Practices
Bio-Pharma companies can no longer afford to rely solely on past experiences when budgeting for a new product launch in today's fast-changing, highly competitive market. This comprehensive benchmark study by Best Practices, LLC investigates current costs as well as budget and staffing allocations required for a successful drug launch.
This study can help bio-pharma leaders to develop competitive launch and pre-launch activity budgets to ensure successful U.S. market entry for new products.
Download Full Report: http://bit.ly/2aMYron
detailed evaluation of the marketing mix of sun pharmaceutical company, the advantages & disadvantages of the 7 P's with reference to the sun pharma and a strategic evaluation of their marketing strategy compared to Dr. Reddy
Global Generic Pharmaceutical Market - Qualitative and Quantitative AnalysisAiswariya Chidambaram
This report was presented at the Pharma Tech 2013 Conference - India A Game Changer in the Pharma Industry at Ahmedabad, India in December 2013. The presentation highlights the overview of the global generic pharmaceuticals market, with particular focus on the key market trends and challenges by therapeutic areas and geographies including the U.S, EU and India. List of key blockbuster drugs scheduled to lose patent protection between 2010 and 2020 have been included. Additionally impact of regulation on generic drugs by region and strategic recommendations for the success of market participants are also covered in this report.
Pharmaceutical Marketing plan, Brand Plan, Launch Plan
1. How To Make Marketing Plan for Pharmaceutical Product ,
2. , What is Marketing Plan? All of the strategies, including the four Ps and segmentation, targeting, and positioning, come together in the marketing plan. , 2
3. , Marketing Plan The marketing plan may be Product specific, market specific, or company-wide plan that describes activities involved in achieving specific marketing objectives within a set timeframe. A market plan begins with the identification (through market research) of specific customer needs and how the firm intends to fulfill them while generating an acceptable level of return. It generally includes analysis of the current market situation (opportunities and trends) and detailed action programs, budgets, sales forecasts, strategies, and projected financial statements. , 3
4. , Pharmaceutical companies Pharmaceutical manufacturing companies typically employ product managers to be responsible for the details of a particular medication. The product manager and his or her team usually assemble marketing plans for the specific products they oversee. Although reprinting a real company’s pharmaceutical marketing plan would be the best way to demonstrate marketing plans, the information contained in such a document is highly confidential. , 4
5. . 5
6. , Content of Marketing Plan Executive Summary Situational Analysis Disease Overview Market Analysis Competitive analysis SWOT Analysis Strategic planning Segmentation Targeting Position Marketing Mix Objectives, Strategies, and Tactics Financial Outlook Control, Evaluation , 6
7. , Executive Summary , 7
8. , Executive Summary Overview of the marketing plan Highlights key areas, decisions, and expected outcomes. , 8
9. , ExecutiveSummary 9 • Total Pharma Market is Rs. 268.2 billion with a growth rate of 11.60%. • Anti Ulcerant (A2B) market is of Rs. 13.29 billion with a value share of 5%, growing by 14.72%. • Anti Ulcerant market is further divided in two therapeutic classes; – Histamine 2 Receptors Antagonists (A2B1) worth Rs. 1.76 bio growing by 3.87. – Proton Pump Inhibitors (A2B2) worth Rs. 11.08 bio growing by 16.62. • The largest pie of this market has been captured by Getz Pharma, together with Risek (Rs. 2.42 bio) & Nexum (Rs.1.05 bio) Getz is enjoying a value share of more than 3 Billion Rupees of PPI market. • Besides Risek & Nexum, Ruling, Esso has become a brand of Rs.737 & 728 m. • Despite fierce competition and much bigger stake holders in market, Brand X managed to make its footing by marking a value share of Rs. 30 million in the first year of Its launch. ,
10. , Situation Analysis ,
11. , Situation Analysis This section describes where your company stands at that moment in time. It includes background on past sales, major competitors, and explanations of recent sales and profit results. ,
12. , Disease Overview •Prevalence rate in country; number of patients
This PPT contains complete analysis of Pharmaceutical Industry including worldwide and nationwide picture, leading organizations, SWOT analysis, Government policies and regulations, challenges and solutions.
Our Product Marketing Plan Playbook is a planning methodology that highlights our premium tool-kit of tools & templates to develop a comprehensive product marketing plan.
Generic Pharma 2.0 Masters of Business Development & MarketingGeneric Pharma 2.0
Introduction to Generic Pharma 2.0
- Business Development Toolkit
- Portfolio Consulting
- Digital Marketing
- Lead Generation & Conversion
- Design & Creative
Description of the Brand Booster Program which includes three innovative marketing approaches: the Brand Preference Mix to increase market share - the Behavioral Prescriber Segmentation to increase the efficiency of field forces and the Individual Prescriber Plan to fine tune the marketing mix
International Market Entry & Development Advisory Specialist - Liow Ren Jan, ...RJ. Liow
“Mr. RJ. Liow is the Founder and CEO of AYS Sdn Bhd, the manufacturer and marketer of Sri Kulai halal ready to eat meals, which are available in major supermarkets in Malaysia such as Cold Storage and Tesco, as well as in airlines and food service providers. Sri Kulai is also available in his very own chain of Sri Kulai RTE Stations, “A one stop F&B outlet for halal ready to eat meals” under a licensing program.
In the short time since 2008, AYS has won numerous awards, including “Best Halal Product” presented at the World Halal Forum in 2009, and “Product Innovation Gold Award” from Malaysia Institute of Food Technology. Liow himself was awarded “Outstanding Leadership Award in World HRD Congress” this year, and “Asia’s thought leader award in Manufacturing” in 2012.
RJ speaks in international conferences. Some of the local and international conferences/events where RJ spoke to included “World Halal Week Conference 2013”, “Effective Entry to Indonesia by Halal Industry Development Corporation Malaysia”, as well as the following upcoming speaking engagements:
1. Food Ingredients Asia - MEGAtrends 2013 (Bangkok, September 2013)
2. National Quality Summit 2013 (Kuala Lumpur, September 2013)
RJ has recently launched a marketing book called “Marketing Halal: Creating New Economy. New Wealth”. Please check out www.marketinghalal.com.my for more insights to a very different kind of marketing book.”
Besides his halal ready to eat meals business, RJ helps companies and government trade organizations around the world to achieve their international business development goals. We generate leads, develop market entry and development strategies, identify and connect distributors and partners in our specialty markets – ASEAN, Middle East, China, Indian Subcontinent and Africa.
His company also provides consultancy services, training and business matching on the followings:
1. Training and consultancy services for setting up of Halal eco-system.
2. Business matching with companies from our network – ASEAN, Middle East, Indian Subcontinent and Africa.
3. Business advisory services on international market entry and development.
4. Speakers on doing business in our network countries.
Parties who are interested in our above services please write to Mr. RJ. Liow at lrj@ays.com.my.
We are also welcome partners who wish to work with us in the sales and marketing of our various programs and services.
International marketing mix: global products and servicesluispachon
International marketing mix: global products and services takes into account what are the characteristics that companies must consider in order to satisfy the local customer's needs.
new product development and product life-cycle strategies sabaAkhan47
In this presentation i have explained the following:
1) definition of NPD (new product development)
2) NPD process
3) MANAGING NEW PRODUCT DEVELOPMENT
a) Customer-centered NPD.
b) Team based NPD.
c) Systematic NPD
4) Product life cycle and its stages.
5) Additional product and service considerations
6) Product decision and social responsibility
7) International product and services marketing.
There are a multitude of risks and issues for corporations and.docxssusera34210
There are a multitude of risks and issues for corporations and industries
operating in the international environment. No doubt, issues such as
inferior quality of products manufactured by companies that engage in
outsourced production, or the use of chemicals in the manufacturing
process of edible products imported back to the U.S., which our regulatory
system considers toxic and which are regulated against within our own
borders. These types of issues can result in a tremendous impact to a
corporation's bottom line, from the financial impact to sales to brand
damage that diminishes their reputation in the marketplace.
Why does a company need to grow?
Suppose you started a company using an innovative product idea you
designed and your corporation was the first one to market and sell this
exciting new product in your home country. Sales immediately took off and
your company found itself growing and branching out in cities all across
your nation. Soon, competitors followed your leadership position, chasing
your market and successfully absorbing some of your sales. In order for
your firm to remain the leader, or to even continue to survive, you would
need to develop strategies that allowed your firm to continue to grow its
market share. If you failed to maintain your market position, over time you
could lose enough of your customer base so as to become unable to
financially continue to stay in business. Not only would you close your
doors, but your employees would lose their jobs.
Corporations spend a large amount of time developing strategies that allow
them to remain competitive in the marketplace, earning profits and re-
investing them into the business in order to grow. When a firm reaches a
saturation point in its home market, one strategy it can deploy to remain
profitable is to move into the global marketplace. The key to remaining
competitive is to constantly, and continually, innovate. For global firms,
innovation is exponentially more challenging.
Profit and Loss - What are they and how do
they impact global strategies?
In order to develop sound global strategies, it is critical to understand
profitability. Simply put, profitability means the degree to which a
corporation has been successful at earning revenues and managing
expenses. The difference between its revenue and its expenses is called
the net profit and the ratio of net profit to revenue is called a net profit
margin. Net profits and net margins are tracked and monitored carefully by
a firm's finance department, along with all other financial data Net margins
reflect how much of each dollar earned by the company has been
translated into profits and is determined by dividing the net profit by
revenue.
While some industries operate on very low, or thin, margins, others operate
on much higher margins. Understanding a firm's finances and industry
profitability norms, assists financial experts in assessing the health of the
firm, a ...
The research study comprises facts and information obtained from various legitimate sources to provide an explained and effortless interpretation of the future state of the market according to past data.
Hemp Based Products Market: Outline
The use of hemp in various products and applications is rising at a great rate over the years. The medicinal benefits of hemp are tremendous and this aspect may bring substantial growth opportunities for the global hemp based products market during the forecast period of 2020-2030.
Government SectorNonprofit SectorPrivate SectorLocal Lev.docxwhittemorelucilla
Government Sector
Nonprofit Sector
Private Sector
Local Level
Job 1
Job 1
Job 1
Job 2
Job 2
Job 2
National Level
Job 1
Job 1
Job 1
Job 2
Job 2
Job 2
Global Level
Job 1
Job 1
Job 1
Job 2
Job 2
Job 2
Proctor & Gamble Strategic Analysis
1
Outline
Introduction
History of P&G
SWOT Analysis
Balanced Scorecard
Communication
Marketing
PEST Analysis
Ethics
Conclusion
Outline of Power Point Presentation
2
Introduction
Looking at internal and external strategies
Developing Markets
Competitive advantage
This report provides a thorough internal as well as external analysis of P&G, identifies its mandate, along with certain strategies that would help it increase its profitability, profit growth and sustain its competitive advantage in both developed and developing markets. Although, P&G has world renowned brands, P&G needs to adopt strategies that enable it to maintain its competitive advantage over its rival.
3
History of P&G
William Procter & James Gamble were founders in 1837.
Total assets at that time:$7,192.24
William A. Procter became first president in 1890.
Ivory soap was first branded product launched in 1879.
(Procter & Gamble, 2012)
Procter & Gamble is a US Global company that provides consumer products in the areas of pharmaceuticals goods founded in 1837.P&G processes operations in more than 80 countries thanks to 300 brands on market
Procter & Gamble is a multinational corporation with more than 300 successful brands worldwide. The company is earning trust of its clients in every part of the world and famous for its steady innovations in all areas of the company. More than 4 billion people use the products of Procter & Gamble daily.
The company has offices in Johannesburg and Cape Town. P& G has its Headquarters in Ohio, US.
4
SWOT Analysis
Strengths:
Diversified brand portfolio
Research and Development
Global Operation
Strong Distribution Network
Weakness:
Online media & Leadership
Dependency
Missing Opportunity
Weakness in beauty care division
Opportunity:
Diversification
Capitalizing on online media
Environment concern
Threats:
Competition
No new innovation
Government regulation
SWOT analysis serves to summarize all of the key findings from the entire situation analysis process including important information about the company’s
internal strengths and weaknesses and important information about external opportunities and threats in the form of consumer trends, competition, and macro
environmental trends.
Strengths: include diverse portfolios, global operations, and strong distribution in which P&G uses to distribute their products and stay ahead of the competition.
Weakness: include a poor online presence, missing opportunity from lack of internet resources, and improvement needed in beauty products.
Opportunity: include P&G’s ability to reach out to ...
Mandala International PDF brochure for Regulatory Affairs, Quality Assurance and Product Registration services for COFEPRIS (Mexico)
Our services:
Product Registration; License Holding
GMP Certification; Quality Assurance
Pharmacovigilance
GAP Analysis
Distributor Search; Market Research; Business Development
Mandala International is world's leading company for COFEPRIS (Mexico) Product Registration.
For more information email me at: david.ortega@mandala-intl.com
The Global Ventilator Market is projected to grow at around 13% CAGR during the forecast period, i.e., 2023-28. Most of the market expansion would be driven by the mounting incidence of chronic & acute respiratory disorders, especially among the rapidly rising elderly population, coupled with the subsequent increase in ICU admissions to treat such illnesses.
An overview of the Human Capital Management Market by Solution report. Human Capital Management Market by Solution (Core HR, Workforce Management, Compensation Management, Performance Management, Recruiting, Learning Management, Employee Collaboration and Engagement), by Industry Verticals , & by Region - Global Forecast to 2019
Aagami Corporate Presentation March 2024Aagami, Inc.
Aagami, Inc., is an Illinois based life sciences consulting firm offering,
1. Strategic Consulting
2. Out/In Licensing support
3. Partnership / Co- development support
4. Funding and Investment Advisory
5. Divestiture/ M&A
6. IP Licensing and Sale
7. Market Entry / Development Strategy
In brief, Aagami brings:
1. Deep Experience of overcoming business and socio-cultural differences of various countries/regions. Our partners have lived and worked in regions such as Japan, Spain, Germany, India, Colombia, apart from the US.
2. Extensive ‘C’ level network nurtured for over 21 years.
3. Global Deal making skills, honed for decades.
4. Partners having combined experience of 250+ years.
5. Supplementing bandwidth to save time, effort & cost.
110+ Bio Pharma clients globally have put their trust in Aagami (180+ assignments) since last 21 years.
This is business plan for Electronics in Bangladesh. If you start business on electronics then you can follow the rules. You will gathers knowledge on these business.as marketing, Branding,Market size, Market overview,Market sigment etc.
RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...BBPMedia1
Grote partijen zijn al een tijdje onderweg met retail media. Ondertussen worden in dit domein ook de kansen zichtbaar voor andere spelers in de markt. Maar met die kansen ontstaan ook vragen: Zelf retail media worden of erop adverteren? In welke fase van de funnel past het en hoe integreer je het in een mediaplan? Wat is nu precies het verschil met marketplaces en Programmatic ads? In dit half uur beslechten we de dilemma's en krijg je antwoorden op wanneer het voor jou tijd is om de volgende stap te zetten.
Explore our most comprehensive guide on lookback analysis at SafePaaS, covering access governance and how it can transform modern ERP audits. Browse now!
Putting the SPARK into Virtual Training.pptxCynthia Clay
This 60-minute webinar, sponsored by Adobe, was delivered for the Training Mag Network. It explored the five elements of SPARK: Storytelling, Purpose, Action, Relationships, and Kudos. Knowing how to tell a well-structured story is key to building long-term memory. Stating a clear purpose that doesn't take away from the discovery learning process is critical. Ensuring that people move from theory to practical application is imperative. Creating strong social learning is the key to commitment and engagement. Validating and affirming participants' comments is the way to create a positive learning environment.
"𝑩𝑬𝑮𝑼𝑵 𝑾𝑰𝑻𝑯 𝑻𝑱 𝑰𝑺 𝑯𝑨𝑳𝑭 𝑫𝑶𝑵𝑬"
𝐓𝐉 𝐂𝐨𝐦𝐬 (𝐓𝐉 𝐂𝐨𝐦𝐦𝐮𝐧𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬) is a professional event agency that includes experts in the event-organizing market in Vietnam, Korea, and ASEAN countries. We provide unlimited types of events from Music concerts, Fan meetings, and Culture festivals to Corporate events, Internal company events, Golf tournaments, MICE events, and Exhibitions.
𝐓𝐉 𝐂𝐨𝐦𝐬 provides unlimited package services including such as Event organizing, Event planning, Event production, Manpower, PR marketing, Design 2D/3D, VIP protocols, Interpreter agency, etc.
Sports events - Golf competitions/billiards competitions/company sports events: dynamic and challenging
⭐ 𝐅𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐬:
➢ 2024 BAEKHYUN [Lonsdaleite] IN HO CHI MINH
➢ SUPER JUNIOR-L.S.S. THE SHOW : Th3ee Guys in HO CHI MINH
➢FreenBecky 1st Fan Meeting in Vietnam
➢CHILDREN ART EXHIBITION 2024: BEYOND BARRIERS
➢ WOW K-Music Festival 2023
➢ Winner [CROSS] Tour in HCM
➢ Super Show 9 in HCM with Super Junior
➢ HCMC - Gyeongsangbuk-do Culture and Tourism Festival
➢ Korean Vietnam Partnership - Fair with LG
➢ Korean President visits Samsung Electronics R&D Center
➢ Vietnam Food Expo with Lotte Wellfood
"𝐄𝐯𝐞𝐫𝐲 𝐞𝐯𝐞𝐧𝐭 𝐢𝐬 𝐚 𝐬𝐭𝐨𝐫𝐲, 𝐚 𝐬𝐩𝐞𝐜𝐢𝐚𝐥 𝐣𝐨𝐮𝐫𝐧𝐞𝐲. 𝐖𝐞 𝐚𝐥𝐰𝐚𝐲𝐬 𝐛𝐞𝐥𝐢𝐞𝐯𝐞 𝐭𝐡𝐚𝐭 𝐬𝐡𝐨𝐫𝐭𝐥𝐲 𝐲𝐨𝐮 𝐰𝐢𝐥𝐥 𝐛𝐞 𝐚 𝐩𝐚𝐫𝐭 𝐨𝐟 𝐨𝐮𝐫 𝐬𝐭𝐨𝐫𝐢𝐞𝐬."
Buy Verified PayPal Account | Buy Google 5 Star Reviewsusawebmarket
Buy Verified PayPal Account
Looking to buy verified PayPal accounts? Discover 7 expert tips for safely purchasing a verified PayPal account in 2024. Ensure security and reliability for your transactions.
PayPal Services Features-
🟢 Email Access
🟢 Bank Added
🟢 Card Verified
🟢 Full SSN Provided
🟢 Phone Number Access
🟢 Driving License Copy
🟢 Fasted Delivery
Client Satisfaction is Our First priority. Our services is very appropriate to buy. We assume that the first-rate way to purchase our offerings is to order on the website. If you have any worry in our cooperation usually You can order us on Skype or Telegram.
24/7 Hours Reply/Please Contact
usawebmarketEmail: support@usawebmarket.com
Skype: usawebmarket
Telegram: @usawebmarket
WhatsApp: +1(218) 203-5951
USA WEB MARKET is the Best Verified PayPal, Payoneer, Cash App, Skrill, Neteller, Stripe Account and SEO, SMM Service provider.100%Satisfection granted.100% replacement Granted.
Personal Brand Statement:
As an Army veteran dedicated to lifelong learning, I bring a disciplined, strategic mindset to my pursuits. I am constantly expanding my knowledge to innovate and lead effectively. My journey is driven by a commitment to excellence, and to make a meaningful impact in the world.
Business Valuation Principles for EntrepreneursBen Wann
This insightful presentation is designed to equip entrepreneurs with the essential knowledge and tools needed to accurately value their businesses. Understanding business valuation is crucial for making informed decisions, whether you're seeking investment, planning to sell, or simply want to gauge your company's worth.
Unveiling the Secrets How Does Generative AI Work.pdfSam H
At its core, generative artificial intelligence relies on the concept of generative models, which serve as engines that churn out entirely new data resembling their training data. It is like a sculptor who has studied so many forms found in nature and then uses this knowledge to create sculptures from his imagination that have never been seen before anywhere else. If taken to cyberspace, gans work almost the same way.
Accpac to QuickBooks Conversion Navigating the Transition with Online Account...PaulBryant58
This article provides a comprehensive guide on how to
effectively manage the convert Accpac to QuickBooks , with a particular focus on utilizing online accounting services to streamline the process.
India Orthopedic Devices Market: Unlocking Growth Secrets, Trends and Develop...Kumar Satyam
According to TechSci Research report, “India Orthopedic Devices Market -Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030”, the India Orthopedic Devices Market stood at USD 1,280.54 Million in 2024 and is anticipated to grow with a CAGR of 7.84% in the forecast period, 2026-2030F. The India Orthopedic Devices Market is being driven by several factors. The most prominent ones include an increase in the elderly population, who are more prone to orthopedic conditions such as osteoporosis and arthritis. Moreover, the rise in sports injuries and road accidents are also contributing to the demand for orthopedic devices. Advances in technology and the introduction of innovative implants and prosthetics have further propelled the market growth. Additionally, government initiatives aimed at improving healthcare infrastructure and the increasing prevalence of lifestyle diseases have led to an upward trend in orthopedic surgeries, thereby fueling the market demand for these devices.
Attending a job Interview for B1 and B2 Englsih learnersErika906060
It is a sample of an interview for a business english class for pre-intermediate and intermediate english students with emphasis on the speking ability.
2. About Generic Pharma 2.0
Founded in 2008 as Genericlicensing Ltd, the business launched the first searchable database of dossiers
available for licensing. Swelled from 500 products to 9000 products in 2012. 3000 licensing teams worldwide
access the data from 150 developers.
In 2011 the company became Generic Pharma 2.0; branching into the OTC & Biosimilar sectors.
In 2012 a publishing division was created with the launch of New Pharma Thinkers in; followed by a Digital
Engagement business, connecting multiple industry websites to generate leads worldwide.
These innovative communication and data businesses have helped create an unparalleled industry network;
creating a unique channel for new opportunities and a platform to offer growth consulting services.
For a more detailed background view this presentation
3. Growth Consulting Services
Generic Pharma 2.0 is unique its in position as the only industry specialist with a global footprint.
We cover all of the major regions with on-the-ground experts.
Offices in London (UK) and Toronto (Canada)
Exclusive consulting associates in:
Asia Western Europe MENA
- Tokyo (Japan) - Hamburg (Germany) - Damascus (Syria)
- Singapore - Madrid & Barcelona (Spain) - Algiers (Algeria)
- Shanghai (China)
- Dhaka (Bangladesh) Eastern Europe Central Asia
- Warsaw (Poland) - via Athens (Greece)
Latin America - Sofia (Bulgaria)
- Buenos Aires (Argentina) Baltics
- Sao Paulo (Brazil) Russia and CIS - Vilnius (Lithuania)
- via Switzerland
All of our team has deep experience in the pharmaceutical industry. Many have been senior managers in
global generic companies; responsible for significant growth and strategic projects.
4. Step 1 - Analysis
Analysis of market entry portfolio Competitor analysis
Qualitative analysis Direct competitors in segment
- Validation of IMS data by in-market expert - Market share
Segment characteristics - Tactics and stated plans
- Trends and changes - Strengths & Weaknesses
- MOH plans Opportunities & Threats
Priorities & Pricing Expectations
- Sequence of introduction - Market penetration scenarios
- Optimal price level - Initial sales projections
Market Entry Options Overview Review of findings
- Regulatory & legal requirements - Select market entry option to investigate
- Likely investment requirement
- Challenges Deliverable
- Probability of success - Written report with data, analysis & recommendations
Cost: $5,000-10,000 per country
5. Step 2 - Planning
SWOT Analysis
- Extensive, in-depth evaluation of chosen market entry strategy
- Select primary research with market 'players' to validate assumptions
Infrastructure & know-how requirements
Regulatory - submissions, updates, PV, reporting
Sales - number of reps, experience, geographical spread, knowledge
Marketing - design, implementation, management
Finance - government filing, processing, management, reporting, tax
Legal - trading entity, management, reporting, timetables
Supply Chain - purchasing, logistics, importation, documentation
Review of findings
- Investment requirements
- Timelines
- Business challenges
Deliverable
- Written report with data, analysis & recommendations
Cost: $5,000-7,500 per country
6. Step 3 - Engagement
Business Model & Product Validation
- Preliminary discussions with 'friendly' contacts to confirm likely success
- Obtain initial feedback on proposed portfolio by long term contacts
- Report competitor intelligence and deal valuations for business case validation
Partners & Customers
- Engage partners with presentation and specific product opportunities
- Build partnership or product business case
- Present rationale and recommendations before next steps
Arrange Meetings
- Set up week long meeting trip with all selected companies
Follow Up
- Work through business evaluation, contract negotiation and relationship building
- Can act as local representative or only provide support when required (ie, face-to-face meetings)
Cost: $10,000-15,000 per 10 qualified meetings with follow up
$5,000-10,000 success fee per agreement signed
7. Step 4 - Operations
Business Set Up Recruitment
Introduction to : - Recommend and engage key operational team
- Lawyers & accountants - Provide cross references and industry reputation checks
- Recommend office space
- Regulatory consultants Cost: $250/hour or $1000/day + expenses
- Ministry of Health agents
- Pharmacovigilance partner
- Importation & logistics partners etc
- Contract sales
Marketing launch
- Improve profile to establish credibility and invite inquiries
- Build trade and channel relationships
- Local language website and marketing materials
Cost: $1500-$5000/month + $2500-5000 for design
Note: We have a dedicated marketing division - DigitalGiants
8. Market Details
Generic Pharma 2.0 can offer market entry services on a per country basis or across a whole region.
The follow pages contact some specific markets believed to be of interest
9. Latin America
Top Level Information
$70bn regional pharma market. 119% growth forecast to 2021.
7 of top 10 highest GDP growth countries are in Latin America.
Considered commercially High Risk by PhRMA, worry of anti-American sentiment.
50/50 in BMI Risk/Reward index. Brazil, Argentina & Mexico above 60% positive.
Strong socialist governments spend big on healthcare but protect domestic industry.
Recommended Strategy
JV/Partner with local company with strong local position and own manufacturing (esp. Brazil).
Set up regional hub in smaller market (e.g Columbia or Chile) where approval times are quicker.
Success Criteria
Value added products; standard generics are all made locally.
Finding the right partner for sales and marketing to compete with major domestic players
Local Expert
Former LATAM Head for leading global generic player
Case Study
Established local business unit for international pharma company; created from ground up to multi-million
revenue operation. Devised strategy, portfolio and oversaw all business operations.
10. Brazil
Top Level Information
203million population. $3.8trillion GDP, growing 7.5% p/a. $12,000 per capita. 21% still below poverty line.
$25billion drug market. Growing middle class provides strong growth (doubled in 10 years!)
Foreign market entrants grew 40% in 3 years to 2011. $2billion of deals with domestic players closed.
Major companies have sales force of 2000; middle management often have $200,000 salaries.
Recommended Strategy
JV/Partner with local company with strong local position and own manufacturing.
Distribution evolving to tech transfer and supply of supply elements (e.g API)
Success Criteria
Value added products; standard generics are all made locally.
Finding the right partner.
Local Experts
Former Director of Brazil subsidiary for major international generic company.
Case Study
Established local business unit for international pharma company; created from ground up to multi-million
revenue operation. Devised strategy, portfolio and oversaw all business operations.
11. Argentina
Top Level Information
42m people, concentrated in the Buenos Aires state, the largest state of the country (25%).
27% GDP growth forecast for 5 years. Current GDP $500 billion
$5.7bn Pharma market. 44% of total sales belong to local companies; the generic sector is 20%.
40-50% reimbursed to the patients: 15% by Pharma Co's, 15% Medical Insurance..
Local industry is very strong. Imports replacement enforced by government where available.
Recommended Strategy
JV/Partner with local company (who must own majority). Local manufacturing highly suggested.
Generics pharma to be sold directly to public and private hospitals and also directly to health insurance.
Success Criteria
Value added products; standard generics are mostly made by local branded generics producers.
Finding the right partner who has connections with major public buyers.
Local Expert
Former International Business Manager for LATAM Spanish region of an Argentinean company. Broad
knowledge and expertise in commercial, regulatory and operations.
Case Study
Design, development and management of two companies, one in Brazil and the other in Mexico as well as
licensing management all over LATAM. National responsibility for all Argentina.
12. USA
Top Level Information
'Pure' generic market dominated by major players and multinational Indian companies; especially for simple
formulations. 505b2 sector increasingly saturated, but still opportunities for complex products. Paragraph IV
/ first-to-file projects still provides greatest return but are highly competitive and litigation is expensive ($3-
5m). Many mid-size companies seeking to grow portfolio quickly. Number of small development companies
seeking partners. Few competitive manufacturing sites except for niche formulations or special handling.
Recommended Strategy
Progressive approach; licensing to strategic partnership to JV/acquisition or greenfield set up.
Model depends on investment capital, risk tolerance, portfolio and long term intent.
Success Criteria
Sales are controlled by a small number of large wholesalers/distributors; it is imperative to have a partner or
sales team with deep relationships. Differentiated portfolio will get most interest, although flexible business
models on holder products are attractive (if reasonable competition).
Local Experts
- CEO Asa Cox is highly connected in the US industry
- 2 Former VP's Business Development for leading global player
Case Study
Engaged all major marketing players and select upcoming speciality companies to license niche European
generic product. Competitive bid scenario resulted in multi-million licensing fee and option for future
products.
13. China
Top Level Information
1.4billion population. 20% of world population. By 2040 China will have a $124trillion economy.
Non-state companies produced 70% of GDP. 20% of luxury good are bought in China.
Chinese hospitals spent $3.5bn; revenue from pharmacies is nearly $7bn.
350m have state pension. 10% personal budget spent on healthcare. Trading up is a mega-trend.
China dominates the API industry, 3000-4000 domestic finished dose manufacturers. 95% generics.
Recommended Strategy
Partner/JV with local manufacturer who owns product approvals; build relationships with key distributors
over time and with strong management team.
Success Criteria
Connections at highest levels of corporations and government. Long term view.
Local Expert
Established international business development business in 1987; connected at all levels and across broad
spectrum of health care industry. Local team on hand to run projects.
Case Study
Evaluated international portfolio for market potential in China; identified suitable partners and engaged.
Build business case, business model and managed all transactional requirements.
14. Algeria
Top Level Information
36m people (80m including neighbouring Morocco & Tunisia), concentrate in north of country.
10% GDP growth forecast for 5 years. $190bn positive trade balance; 99% oil.
$3bn Pharma market. 86% public funded. 79% generic market. 80-100% reimbursed. Strong Gx incentives.
Industry focused internally, many imports banned. Value still 64% on imports.
Recommended Strategy
JV/Partner with local company (who must own majority).
Distribution evolving to tech transfer and supply of supply elements (e.g API)
Success Criteria
Value added products; standard generics are all made locally.
Finding the right partner.
Local Expert
Established local businesses for European clients. Founder of only pharmaceutical exhibition in country.
Business background with best network of decision makers available.
Case Study
Evaluated portfolio for major international generic company. Provided 5-year forecasts based on tiered
partnership recommendation. Engaged local companies and established local JV.
15. Baltics
Top Level Information
6.5 million population (3m-LIT, 2.2-LV, 1.3-EE), $138 million GDP, growing 3% p/a.
$20,000 per capita, all 3 countries are European Union members. 800 million Euro
drug market, growing 3% p/a; 90%-retail, 10%-hospital; 70%-Rx, 30%-OTC
generics by value (38%-LIT; 34%-LV; 28%-EE), generics by units (53%-LIT, 58%-LV, 49%-EE)
Reimbursement budgets for pharmaceuticals are flat; 0.5 million Euro - average sales.
Recommended major companies have sales force of 30 to target pharmacy chains.
Recommended Strategy
1) Licensing to one or several partners 2) JV/acquisition 3) Representative office.
Model depends on investment capital, risk tolerance, portfolio and long term intent.
Success Criteria
Sales are controlled by a small number of large pharmacy chains; it is imperative to have a partner or sales
team with deep relationships. Differentiated portfolio will get most interest, although flexible business
models on holder products are attractive (if reasonable competition).
Local Expert
Former Lithuania country manager and regional head for leading ethical and generic manufacturing
companies. Former member of the board of the pharma industry association. Strong relationships
throughout region since launching independent consulting business for licensing in/out
Case Study
Established local business unit for several international pharma companies; created from ground up to a
several million revenue operation. Devised strategy, portfolio and oversaw all business operations.
16. Russia & CIS
Top Level Information
The CIS market in 2011 was $25.5bn of which Russia was $18.8bn where the growth rate in 2012
and 2012 will be ±10%. In Russia there is the so-called “2020 Vision” where the declared aim of the
Russian government is to have 50% (by value) of all medicines sold in Russian to be made locally.
Corruption is an issue with most CIS countries at position 130 or below; the exceptions are Moldova
(36) and Georgia (51). (Canada has position 9).
Recommended Strategy
In view of the current long registration time in Russia (>2.5 years), it is best to start in in parallel to
Russia with some of the smaller markets where sales can be achieved faster. Choose a local distributor
with adequate promotional capabilities; representative office in larger markets.
Success Criteria
Value added products: standard generics are either made locally or imported from India, sometimes
China; finding the right partners; long term view.
Local Expert
Former Export Director of Middle sized companies active in the CIS, Balkans and Baltic States with
>20 years’ experience; contacts at all levels throughout the CIS.
Case Study
Established business from scratch in all the CIS markets for ethical and generic manufacturers.
Devised strategy, portfolio and oversaw all business activities.